Preconditioning for Rewarming

  • Nariyuki Hayashi
  • Dalton W. Dietrich


Preconditioning for rewarming means the premanagement required to prevent various complications during the rewarming stage [5,6]. Without suitable management, safe rewarming is difficult. The treatment of hyperglycemia, hypo-albuminemia, blood-brain barrier (BBB) dysfunction, respiratory dysfunction, and complication of infection are especially important [4, 5, 6].


Enteral Nutrition Brain Edema Methicillin Resistant Staphylococcus Aureus Hypothermia Treatment Respiratory Muscle Weakness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dietrich WD, Busto R, Halley M, Valdes I (1990) The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol 49:486–497PubMedCrossRefGoogle Scholar
  2. 2.
    Fedor EJ, Fisher ER, Lee SH, Weitzel WK, Fisher B (1956) Effect of hypothermia upon induced bacteremia. Proc Soc Exp Biol Med 93:510–512PubMedGoogle Scholar
  3. 3.
    Harrington D, Chua TP, Coast AJS (2000) The effect of solbutamol on skeletal muscle in chronic heart failure. Int J Cardiol 73:257–265PubMedCrossRefGoogle Scholar
  4. 4.
    Hayashi N (1995) Cerebral hypothermia treatment. In: Hayashi N (ed) Cerebral hypothermia treatment. Sogo Igaku, Tokyo, pp 1–105Google Scholar
  5. 5.
    Hayashi N (1997) Prevention of vegetation after severe head trauma and stroke by combination therapy of cerebral hypothermia and activation of immunedopaminergic nervous system. Proc Soc Treat Coma 6:133–145Google Scholar
  6. 6.
    Hayashi N (2000) The clinical issue and effectiveness of brain hypothermia treatment for severe brain injured patients. In: Hayashi N (ed) Brain hypothermia. Springer, Berlin Heidelberg New York Tokyo, pp 121–151CrossRefGoogle Scholar
  7. 7.
    Kagawa M, Nagao S, Bemana I (1996) Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study. J Neurotrauma 13:273–279PubMedCrossRefGoogle Scholar
  8. 8.
    Kow LM, Pfaff DW (1986) Vasopressin excites ventromedial hypothalamus glucose-responsive neurons in vitro. Physiol Behav 37:153–158PubMedCrossRefGoogle Scholar
  9. 9.
    Laterra J, Goldstein GW (2000) Ventricular organization of cerebrospinal fluid: blood brain barrier, brain edema, and hydrocephalus. In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of neural science. McGraw-Hill, New York, pp 1288–1294Google Scholar
  10. 10.
    Leibowitz SF (1999) Macronutrients and brain peptides: what they do and how they respond. In: Berthoud HR, Seeley RJ (eds) Neural and metabolic control of macronutrient intake. CRC, Boca Raton, pp 389–406Google Scholar
  11. 11.
    Leibowiz SF, Sladek C, Spencer L, Temple D (1988) Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull 21:905–912CrossRefGoogle Scholar
  12. 12.
    Lin TW, Kuo YS (1996) Acute pulmonary oedema following administration of vasopressin for control of massive GI tract haemorrhage in a major burn patient. Burns 22:73–75PubMedCrossRefGoogle Scholar
  13. 13.
    McClain CJ, Hennig B, Ott L, Goldblum S, Young AB (1988) Mechanisms and implications of hypoalbuminemia in head-injured patients. J Neurosurg 69:386–392PubMedCrossRefGoogle Scholar
  14. 14.
    Pardridge WM (1997) Blood-brain barrier transport mechnisms. In: Welch KMA, Caplan LR, Reise DJ, Siesjo BK, Weir B (eds) Cerebrovascular disease. Academic, New York, pp 21–25CrossRefGoogle Scholar
  15. 15.
    Payne LC, Obal F Jr, Opp MR, Krueger JM (1999) Stimulation and inhibition of growth hormone secretion by IL1: the involvement of growth hormone. Neuroendoclinology 56:118–123CrossRefGoogle Scholar
  16. 16.
    Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic system for body energy balance. In: Colmers WF, Wahlestedt C (eds) Biology of neuropeptide Y and related peptide. Humana Press, Totowa, NJ, pp 457–509CrossRefGoogle Scholar
  17. 17.
    Temple DL, Leibowitz SF (1994) The neuropeptide Y system (hypothalamus) has a dense concentration of glucocorticoide (type II) receptors that mediate carbon hydrate intake. J Neuroendocrinol 6:479–501CrossRefGoogle Scholar

Copyright information

© Springer Japan 2004

Authors and Affiliations

  • Nariyuki Hayashi
    • 1
    • 2
  • Dalton W. Dietrich
    • 3
    • 4
  1. 1.Nihon University Emergency Medical CenterTokyoJapan
  2. 2.Department of Emergency and Critical Care MedicineNihon University School of MedicineTokyoJapan
  3. 3.Department of Neurological Surgery, Neurology and Cell Biology and AnatomyUniversity of Miami School of MedicineMiamiUSA
  4. 4.The Miami Project to Cure ParalysisMiamiUSA

Personalised recommendations